5-Fluorouracil response in a large panel of colorectal cancer cell lines is associated with mismatch repair deficiency.
BACKGROUND: Colorectal cancer is (CRC) one of the commonest cancers and its therapy is still based on few drugs. Currently, no biological criteria are used to choose the most effective of the established drugs for treatment. METHODS: A panel of 77 CRC cell lines was tested for sensitivity to 5-fluo...
Main Authors: | Bracht, K, Nicholls, A, Liu, Y, Bodmer, W |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2010
|
Similar Items
-
DNA mismatch repair genes and colorectal cancer.
by: Wheeler, J, et al.
Published: (2000) -
Intrinsic Resistance to Immune Checkpoint Blockade in a Mismatch Repair–Deficient Colorectal Cancer
by: Liu, David, et al.
Published: (2020) -
Drug responses and predictive markers for sensitivity in colorectal cancer cell lines
by: Bracht, K, et al.
Published: (2009) -
Intraportal 5-fluorouracil for colorectal cancer: the AXIS trial.
by: Garten, L, et al.
Published: (1992) -
Mismatch Repair Testing in Colorectal Cancer - Is Less More?
by: Hutchins, G, et al.
Published: (2012)